Histopathology Following CCH Injection

NCT04236635 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Characteristics of Subcutaneous Tissue

Interventions

DRUG: Collagenase Clostridium Histolyticum Single Injection Technique
DRUG: Collagenase Clostridium Histolyticum Multiple Injection Technique

Sponsor

Endo Pharmaceuticals